Sandy Bassin, MD Medical Reviewer Sandy Bassin, MD, is an endocrinology fellow at Mount Sinai in New York City
doi: 10.3389/fcell.2024.1435125 Received 19 May 2024 Accepted 27 June 2024 Published 11 July 2024 Volume 12 - 2024 Edited by Takehito Ouchi, Tokyo Dental College, Japan Reviewed by Kui Xu, Anhui University of Chinese Medicine, China Xiaolei Li, University of Pennsylvania, United States Updates Copyright 2024 Zheng, Liu, Sun and Meng
FDA Oral Wegovy Approval: What the December 22, 2025 Decision Means The FDA's approval of the Wegovy pill represents the first oral GLP-1 medication cleared specifically for weight loss
Classification and selection of the most relevant articles based on predefined evaluation criteria
A beverage that meets all five criteria, high protein, zero added sugar, whole food ingredients, controlled portions, and functional add-on availability, qualifies as GLP-1 friendly for foodservice purposes
Logistics Optimization and Supply Chain Management Coordinating paperwork like commercial bills, packing lists, certificates of origin, and phytosanitary certificates is part of international purchasing